Literature DB >> 6735361

A monoclonal antibody, NCRC-11, raised to human breast carcinoma. 1. Production and immunohistological characterization.

I O Ellis, R A Robins, C W Elston, R W Blamey, B Ferry, R W Baldwin.   

Abstract

The production of a mouse monoclonal IgM antibody, NCRC-11, raised against human breast carcinoma is described. It has been characterized immunohistologically. The antigen recognised has a wide but highly specific distribution in normal tissues, being virtually confined to the surface of certain epithelial cell types. It is found in some forms of epithelial metaplasia and most epithelial malignancies, particularly adenocarcinomas. The heterogeneity of staining in mammary carcinomas is outlined and is of particular interest. The immunohistological staining distribution of NCRC-11 is similar to other antibodies, including anti-epithelial membrane antigen, which were raised against human milk fat globule membrane. A competition experiment with some of these antibodies, using a flow cytofluorimeter, showed competition with one antibody, LICR LON/M8.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6735361     DOI: 10.1111/j.1365-2559.1984.tb02360.x

Source DB:  PubMed          Journal:  Histopathology        ISSN: 0309-0167            Impact factor:   5.087


  22 in total

1.  Human monoclonal anti-idiotypic antibody to the tumour-associated antibody 791T/36.

Authors:  E B Austin; R A Robins; L G Durrant; M R Price; R W Baldwin
Journal:  Immunology       Date:  1989-08       Impact factor: 7.397

2.  Tumour marker immunoreactivity in adenocarcinoma.

Authors:  I O Ellis; A Hitchcock
Journal:  J Clin Pathol       Date:  1988-10       Impact factor: 3.411

3.  Cellular effects of tamoxifen in primary breast cancer.

Authors:  J F Robertson; I O Ellis; R I Nicholson; A Robins; J Bell; R W Blamey
Journal:  Breast Cancer Res Treat       Date:  1992-01       Impact factor: 4.872

4.  Critical evaluation of monoclonal antibody staining in breast carcinoma.

Authors:  D M Parham; G Coghill; A J Robertson
Journal:  J Clin Pathol       Date:  1989-08       Impact factor: 3.411

5.  Reactivity of an anti-(human gastric carcinoma) monoclonal antibody with core-related peptides of gastrointestinal mucin.

Authors:  M R Price; M Sekowski; G Y Yang; L G Durrant; R A Robins; R W Baldwin
Journal:  Cancer Immunol Immunother       Date:  1991       Impact factor: 6.968

6.  Use of tumour marker immunoreactivity to identify primary site of metastatic cancer.

Authors:  A R Gamble; J A Bell; J E Ronan; D Pearson; I O Ellis
Journal:  BMJ       Date:  1993-01-30

7.  Quantitation of human milk fat globule (HMFG1) expression in breast carcinoma and its association with survival.

Authors:  D M Parham; W Slidders; A J Robertson
Journal:  J Clin Pathol       Date:  1988-08       Impact factor: 3.411

8.  Structural and computational investigations of the conformation of antigenic peptide fragments of human polymorphic epithelial mucin.

Authors:  M J Scanlon; S D Morley; D E Jackson; M R Price; S J Tendler
Journal:  Biochem J       Date:  1992-05-15       Impact factor: 3.857

9.  A mucin-like glycoprotein identified by MAG (mouse ascites Golgi) antibodies. Menstrual cycle-dependent localization in human endometrium.

Authors:  H J Kliman; R F Feinberg; L B Schwartz; M A Feinman; E Lavi; E L Meaddough
Journal:  Am J Pathol       Date:  1995-01       Impact factor: 4.307

10.  Detection of polymorphic epithelial mucins in the serum of systemic breast cancer patients using the monoclonal antibody, NCRC-11.

Authors:  M R Price; A J Clarke; J F Robertson; C O'Sullivan; R W Baldwin; R W Blamey
Journal:  Cancer Immunol Immunother       Date:  1990       Impact factor: 6.968

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.